Detalles de la búsqueda
1.
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
Pediatr Blood Cancer
; 66(7): e27736, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968542
2.
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 62(4): 629-36, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25704135
3.
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
N Engl J Med
; 363(14): 1313-23, 2010 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20879880
4.
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
J Clin Oncol
; 41(17): 3149-3159, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098238
5.
Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.
Blood
; 123(9): 1426-7, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24578498
6.
Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.
Pediatr Blood Cancer
; 54(1): 103-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19774634
7.
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 51(6): 747-53, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18704922
8.
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
J Clin Oncol
; 23(27): 6466-73, 2005 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16116152
9.
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
J Clin Oncol
; 23(34): 8819-27, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16314642
10.
Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study.
J Clin Oncol
; 23(27): 6499-507, 2005 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16170159
11.
Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study.
J Clin Oncol
; 22(6): 999-1006, 2004 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15020603
12.
Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study.
J Clin Oncol
; 22(20): 4119-26, 2004 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15483021
13.
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
J Clin Oncol
; 22(13): 2691-700, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15226336
14.
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
J Clin Oncol
; 20(12): 2789-97, 2002 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12065555
15.
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.
Cancer Lett
; 228(1-2): 257-66, 2005 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-16024170
16.
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
J Clin Oncol
; 30(15): 1842-8, 2012 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22529259
17.
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.
J Clin Oncol
; 28(24): 3808-15, 2010 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660830
18.
PTEN deficiency is a common defect in juvenile myelomonocytic leukemia.
Leuk Res
; 33(5): 671-7, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19010541
19.
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
J Clin Oncol
; 26(6): 913-8, 2008 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18281664
20.
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
Blood
; 111(3): 1124-7, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18000165